Please provide your email address to receive an email when new articles are posted on . Eyes that received LipiFlow treatment before cataract surgery had improved meibomian gland scores compared with ...
The National Eye Institute, part of the National Institutes of Health, awarded Jason J. Nichols, OD, MPH, PhD, FAAO, a five-year, $1.9 million R01 grant to study potential molecular markers in ...
Meibomian gland dysfunction (MGD) is the major cause of evaporative dry eye disease (EDED) and dysfunction is widely thought to mechanistically involve ductal hyperkeratinization, plugging and ...
Please provide your email address to receive an email when new articles are posted on . A single LipiFlow procedure can improve meibomian gland function and relieve symptoms, according to a review ...
TEL AVIV, Israel--(BUSINESS WIRE)--Azura Ophthalmics Ltd., a clinical-stage biopharmaceutical company developing a new therapeutic class of Ophthalmic Keratolytics for ocular surface diseases, today ...
LipiFlow®, an advanced treatment for dry eye, is now available at Wang Vision Institute. Research indicates the majority of patients with dry eye have concurrent meibomian gland dysfunction. Healthy ...
Meibomian gland dysfunction (MGD) is underdiagnosed and undertreated, with asymptomatic disease far more common than symptomatic disease. As the condition progresses, patients who were initially ...
"DelveInsight’s, “Meibomian Gland Dysfunction- Pipeline Insight, 2025” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Meibomian Gland Dysfunction pipeline landscape ...
A team led by Mount Sinai researchers has identified stem cell populations and mechanisms underlying age-related degeneration in glands that are vital to eye function. The findings, published in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results